How fat molecules in blood affect liver cancer radiotherapy
Part of Cancer, Digestive system clinical trials.
This study looks at whether certain fats in your blood can help predict how well radiotherapy works for liver cancer. If you are getting radiation for liver cancer, your blood samples may help doctors learn more about your treatment response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with primary liver cancer (cancer that started in your liver).
- Your doctor has decided that you need radiation therapy as part of your treatment.
- You are expected to live at least 3 months or more.
- You do not have other types of cancer or severe health conditions like uncontrolled diabetes, serious heart or lung problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people having liver cancer surgery. It will look at certain fats in your blood to see if they can help doctors understand and track liver cancer better.
This trial is testing whether a protein called CHI3L1 in your blood can help predict how well tumors will respond to radiation therapy. It is open to people with several types of cancer who are in good overall health.
This study looks for a new blood marker that may predict how well liver cancer will respond to radiation and what outcomes to expect. It’s for people with hepatitis B–related liver cancer who can safely receive radiation to the liver tumor.
This trial studies how radiation therapy affects the immune system and outcomes in people with liver cancer. It may help doctors understand better ways to treat the disease.
This trial is for people with liver cancer (hepatocellular carcinoma) who are about to receive a type of internal radiation therapy called TARE (also known as radioembolization). Researchers want to learn more about how the cancer responds to this treatment using scans and biopsies. You might be a good fit if you have not had any prior treatment for your liver cancer.
This study tests new blood tests and MRI scans to see how well your liver works during radiation therapy for liver cancer. It may help doctors better plan treatment and monitor your liver health.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.